Top Markets
Coin of the day
Medeon Biodesign, Inc. Medeon Biodesign, Inc.

Medeon Biodesign, Inc.

6499
Classement en actions #17677
Medeon Biodesign, Inc. engages in the research and development, manufacturing,... Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
Prix de l'action
$2.38
Capitalisation boursière
$231.21M
Changement (1 jour)
0.94%
Changement (1 an)
-25.60%
Pays
TW
Échange Medeon Biodesign, Inc. (6499)

Catégorie

Historique des dividendes pour Medeon Biodesign, Inc. (6499)
Medeon Biodesign, Inc. (symbole boursier : 6499) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour Medeon Biodesign, Inc. (6499) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes
Entreprise Nombre de paiements de dividendes Pays
90.00%
US
58.00%
KR
0.00%
JP
52.00%
JP
0.00%
CN